Is provision of cheap drugs having limited effects in the fight against HCV in SE Asia?
Taiwan’s Pursuit of Precisi...
“The rise of the middle cla...
IPO Fever Grips Biotech Ind...
MedTech’s sustainability mi...
Why multi-use real estate is in dem
How Thai Biotech and Healthtech is
Sartorius invests $100 M in new CoE
China-based biotech firm MGI unveil
Japan's Takeda Pharma to advance re
Singapore develops promising vaccin
Are biotech IPOs poised for an upswing?